Insmed Inc (INSM)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$164.06

Buy

$166.50

arrow-down$-31.91 (-16.08%)

Prices updated at 19 Dec 2025, 00:58 EST

Prices minimum 15 mins delay

Prices in USD

Insmed Inc is a global biotechnology company. It is focused on developing novel therapies that focus primarily on lung diseases.

NASDAQ

1.38%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$172.31 - $161.02
	$212.75 - $60.40
	-
	42,326.25m
	-
	-
	13,491,281
	44.76
	2,695,098.07
	1.77
	179.38m
	US4576693075
	-6.19
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.